Cannabis Central: Charlotte's Web Q2 Financials Show Flat Revenue & Greater Losses

Charlotte's Web Holdings Inc., announced its Q2 financial results today for the period ended June 30, 2020, and they reflected the negative impact of the COVID-19 pandemic on its sales and operation.

Charlotte's Web Holdings Inc. (CWBHF), the market leader in the production and distribution of innovative hemp-derived cannabidiol ("CBD") wellness products announced its Q2 financial results today for the period ended June 30, 2020, and they reflected the negative impact of the COVID-19 pandemic on its sales and operation.

Q2 Financial Highlights  (Unless otherwise noted, all results are presented in U.S. dollars and compared to the previous quarter.)

  • Revenue: +0.5% to $21.6M
    • Direct-to-Consumer: +9.9% to 71.8% of total
    • Business-to-Business: -17.6% to 28.2% of total
  • Gross Profit: -23.8% to $11.5M
  • Operating Expenses: +26.6% to 29.5%
  • Net Loss: +25.2% to $(14.4M)
  • Loss/Share: +30% to $(0.13)
  • Adj. EBITDA: Unchanged at $(5.7M)
  • Cash Balance: +88% to $99.8M

Operational Highlights For Q2

  • Completed acquisition of Abacus Health Products, Inc.
  • Commenced Abacus product cross-selling though Charlotte's Web leading DTC channel
  • Moved warehousing and fulfillment operations into new 137,000 sq ft facility
  • Surpassed 21,000 unique retail doors
  • Completed $54 million financing for expansion and working capital
  • Awarded B Corp™ certification for excellence in ESG to become the only publicly traded CBD B-Corp certified company

Management Commentary

Deanie Elsner, CEO, had the following comments:

  • "Second-quarter revenue was below expectations due to the impact of COVID-19 on retail sales...[although] Direct-to-Consumer sales increased largely offsetting declines in Business-to-Business retail sales. 
  • We made excellent progress building out our infrastructure and expanding our products portfolio with the closing of the Abacus acquisition...
  • We look forward to realizing  more cross-selling revenue synergies with Abacus through our FDM partners." 

Added Russ Hammer, Chief Financial Officer:

  • "..Without a meaningful opening up of the economy and health practitioner channel we expect only flat to modest consolidated net revenue growth for 2020.
  • Our long view market opportunity remains intact and we continue to add new customers, doors, and products.
  • Our Q3 revenues are trending ahead of Q2 sales levels and we anticipate reopening of retail locations in the U.S. will support a positive growth trend.
  • As we see resolutions in COVID-19 and hemp CBD regulations or legislation we can see the category build towards its full potential." 

Stock Performance

Charlotte's Web is one of the 25 pure-play stocks in the munKNEE Pure-Play Pot Stock Portfolio that trades for at least US$1/share.

  • While the 14 multi-state operators (MSOs) in the portfolio are UP 13.8%, on average, YTD, Charlotte's Web is DOWN 60.8% YTD.
  • Furthermore, while the MSO constituents in the portfolio are UP 43.7%, on average, in the last 2.5 months (i.e. since June 30th) Charlotte's Web stock price is DOWN 21.2% as illustrated in the chart below:

(Click on image to enlarge)

 

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample here).

STOCKS IN THIS ARTICLE

Comments